Jiwu Wei

8.6k total citations
59 papers, 1.9k citations indexed

About

Jiwu Wei is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Jiwu Wei has authored 59 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 22 papers in Molecular Biology and 17 papers in Oncology. Recurrent topics in Jiwu Wei's work include Virus-based gene therapy research (24 papers), CAR-T cell therapy research (11 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Jiwu Wei is often cited by papers focused on Virus-based gene therapy research (24 papers), CAR-T cell therapy research (11 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Jiwu Wei collaborates with scholars based in China, Germany and United States. Jiwu Wei's co-authors include Gang Meng, Jie Dong, Junhua Wu, Xia Mao, Decai Yu, Shuguang Zuo, Shiqun Wang, Min Wei, Binghua Li and Christian Beltinger and has published in prestigious journals such as Nature Communications, The Journal of Immunology and PLoS ONE.

In The Last Decade

Jiwu Wei

57 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiwu Wei China 25 941 527 476 475 381 59 1.9k
Mohanraj Ramachandran Sweden 22 1.1k 1.1× 916 1.7× 468 1.0× 560 1.2× 331 0.9× 46 3.5k
Shibing Wang China 24 721 0.8× 540 1.0× 224 0.5× 224 0.5× 456 1.2× 78 1.5k
Hua Xiang China 30 1.2k 1.3× 433 0.8× 355 0.7× 575 1.2× 176 0.5× 98 2.6k
Tae Woo Kim South Korea 30 1.2k 1.3× 710 1.3× 289 0.6× 807 1.7× 121 0.3× 65 2.3k
Qian Mei China 29 1.6k 1.7× 792 1.5× 888 1.9× 827 1.7× 194 0.5× 68 3.0k
Young Song United States 28 2.6k 2.7× 728 1.4× 671 1.4× 704 1.5× 835 2.2× 56 3.9k
Todd W. Ridky United States 26 1.8k 1.9× 926 1.8× 404 0.8× 306 0.6× 242 0.6× 44 3.2k
Øystein Garred Norway 20 1.1k 1.2× 304 0.6× 246 0.5× 469 1.0× 162 0.4× 43 2.2k

Countries citing papers authored by Jiwu Wei

Since Specialization
Citations

This map shows the geographic impact of Jiwu Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiwu Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiwu Wei more than expected).

Fields of papers citing papers by Jiwu Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiwu Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiwu Wei. The network helps show where Jiwu Wei may publish in the future.

Co-authorship network of co-authors of Jiwu Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Jiwu Wei. A scholar is included among the top collaborators of Jiwu Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiwu Wei. Jiwu Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Peng, Qian, Yifeng Han, Mengdi Wu, et al.. (2025). A bispecific antibody targeting PD-L1/TNFR2 increases tumor targeting and enhances antitumor efficacy in colorectal cancer. Journal for ImmunoTherapy of Cancer. 13(11). e013001–e013001.
3.
Kang, Xiaozheng, Yifeng Han, Yuxin Li, et al.. (2024). In situ blockade of TNF-TNFR2 axis via oncolytic adenovirus improves antitumor efficacy in solid tumors. Molecular Therapy. 33(2). 670–687. 2 indexed citations
4.
Wang, Shibing, et al.. (2024). An oncolytic vaccinia virus encoding hyaluronidase reshapes the extracellular matrix to enhance cancer chemotherapy and immunotherapy. Journal for ImmunoTherapy of Cancer. 12(3). e008431–e008431. 39 indexed citations
5.
Yao, Bing, Qi‐Xiang Li, Bing Chen, et al.. (2024). NatD epigenetically activates FOXA2 expression to promote breast cancer progression by facilitating MMP14 expression. iScience. 27(2). 108840–108840. 8 indexed citations
6.
Wang, Shiqun, Lu Li, Shuguang Zuo, et al.. (2022). Metabolic-related gene pairs signature analysis identifies ABCA1 expression levels on tumor-associated macrophages as a prognostic biomarker in primary IDHWT glioblastoma. Frontiers in Immunology. 13. 869061–869061. 5 indexed citations
7.
Xu, C. F., Jie Dong, Shuguang Zuo, et al.. (2020). Liraglutide activates nature killer cell-mediated antitumor responses by inhibiting IL-6/STAT3 signaling in hepatocellular carcinoma. Translational Oncology. 14(1). 100872–100872. 26 indexed citations
8.
Mao, Xia, Dongjun Luo, Jie Dong, et al.. (2019). Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy. Journal of Experimental & Clinical Cancer Research. 38(1). 408–408. 36 indexed citations
9.
Meng, Gang, Mingyue Fang, Binghua Li, et al.. (2019). Fludarabine as an Adjuvant Improves Newcastle Disease Virus-Mediated Antitumor Immunity in Hepatocellular Carcinoma. Molecular Therapy — Oncolytics. 13. 22–34. 13 indexed citations
10.
11.
Li, Binghua, et al.. (2018). The anti-inflammatory NHE-06 restores antitumor immunity by targeting NF-κB/IL-6/STAT3 signaling in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 102. 420–427. 24 indexed citations
12.
Xu, C. F., et al.. (2018). Proof-of-principle that a decoy virus protects oncolytic measles virus against neutralizing antibodies. PubMed. Volume 7. 37–41. 4 indexed citations
13.
Chen, Aiping, Yonghui Zhang, Gang Meng, et al.. (2017). Oncolytic measles virus enhances antitumour responses of adoptive CD8+NKG2D+ cells in hepatocellular carcinoma treatment. Scientific Reports. 7(1). 5170–5170. 38 indexed citations
14.
Mao, Xia, Gang Meng, Min Li, & Jiwu Wei. (2014). Mitophagy in Viral Infections. DNA and Cell Biology. 33(11). 739–742. 10 indexed citations
15.
Wei, Jiwu, et al.. (2014). Attenuated measles virus controls pediatric acute B-lineage lymphoblastic leukemia in NOD/SCID mice. Haematologica. 99(6). 1050–1061. 9 indexed citations
16.
Mao, Xia, Patrick Gonzalez, Chunyan Li, et al.. (2014). Mitophagy Enhances Oncolytic Measles Virus Replication by Mitigating DDX58/RIG-I-Like Receptor Signaling. Journal of Virology. 88(9). 5152–5164. 99 indexed citations
17.
Wei, Jiwu, Peter Duewell, Sabine Hoves, et al.. (2013). Therapeutic Efficacy of Bifunctional siRNA Combining TGF-β1 Silencing with RIG-I Activation in Pancreatic Cancer. Cancer Research. 73(6). 1709–1720. 123 indexed citations
18.
Xie, Jinbing, Yi Cao, Xia Mao, et al.. (2013). One‐Step Photo Synthesis of Protein–Drug Nanoassemblies for Drug Delivery. Advanced Healthcare Materials. 2(6). 795–799. 24 indexed citations
19.
Wei, Jiwu. (2011). New technology used in strong motion seismograph. Dizhen gongcheng yu gongcheng zhendong. 1 indexed citations
20.
Wei, Jiwu, Sabine Blum, Marcus M. Unger, et al.. (2004). Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery. Cancer Cell. 5(5). 477–488. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026